产品编号:B367500
产品规格:10mg
产品价格:面议
| 标准品编号: | B367500 |
| 名称: | BGT 226 |
| 别名: | NVP BGT226; NYP-BGT 226; 1,3-Dihydro-8-(6-methoxy-3-pyridinyl)-3-methyl-1-[4-(1-piperazinyl)-3-(trifluoromethyl)phenyl]-2H-Imidazo[4,5-c]quinolin-2-one (2Z)-2-Butenedioate (1:1); 8-(6-Methoxypyridin-3-yl)-3-methyl-1-(4-(piperazin-1-yl)-3-(trifluoromethyl)phenyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one Maleate |
| CAS号: | 1245537-68-1 |
| 分子式: | C₃₂H₂₉F₃N₆O₆ |
| 分子量: | 650.6 |
| 类别: | Research Tools; |
| 应用: | BGT 226 is a novel phosphatidyl inositol-3 kinase/mammalian target of rapamycin (PI3K/mTOR ) dual inhibitor which has shown to be effective with gefitinib in epidermal growth factor receptor (EGFR) inhibitor-sensitive non-small cell lung cancer (NSCLC) therapy. |
| 文献 | |